Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Teh Seng Pharmaceutical Mfg Co EV-to-EBITDA?
Teh Seng Pharmaceutical Mfg CoROCO:7860 30 EV-to-EBITDA is 13.58 as of Sep. 20, 2026, which is 39% above its 10-year median of 9.75. GuruFocus rates ROCO:7860 with a GF Score™ of 30/100. The stock has 5 warning signs investors should review. Among 746 Drug Manufacturers companies, Teh Seng Pharmaceutical Mfg Co ranks worse than 53.08% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Teh Seng Pharmaceutical Mfg Co's enterprise value is NT$2,081.7 Mil.
Teh Seng Pharmaceutical Mfg Co's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was NT$153.3 Mil. Therefore, Teh Seng Pharmaceutical Mfg Co's EV-to-EBITDA for today is 13.58.
The historical rank and industry rank for Teh Seng Pharmaceutical Mfg Co's EV-to-EBITDA or its related term are showing as below:
ROCO:7860'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 7.43 Med: 9.75 Max: 13.57
Current: 13.57
During the past 4 years, the highest EV-to-EBITDA of Teh Seng Pharmaceutical Mfg Co was 13.57. The lowest was 7.43. And the median was 9.75.
ROCO:7860's EV-to-EBITDA is ranked worse than 53.08% of 746
companies
in the Drug Manufacturers industry
Industry Median: 12.395
vs ROCO:7860: 13.57
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Teh Seng Pharmaceutical Mfg Co (ROCO:7860) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Teh Seng Pharmaceutical Mfg Co's PE Ratio (TTM) for today is calculated as:
Teh Seng Pharmaceutical Mfg Co's share price for today is NT$70.40.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Teh Seng Pharmaceutical Mfg Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 was NT$2.788.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Teh Seng Pharmaceutical Mfg Co EV-to-EBITDA Chart
Teh Seng Pharmaceutical Mfg Co Annual Data
Trend
Dec22
Dec23
Dec24
Dec25
EV-to-EBITDA
-
-
-
12.31
Teh Seng Pharmaceutical Mfg Co Semi-Annual Data
Jun24
Dec24
Jun25
Dec25
Jun26
EV-to-EBITDA
-
-
-
12.33
12.05
ROCO:7860 vs ZTS: EV-to-EBITDA Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Teh Seng Pharmaceutical Mfg Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Teh Seng Pharmaceutical Mfg Co EV-to-EBITDA vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Teh Seng Pharmaceutical Mfg Co's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Teh Seng Pharmaceutical Mfg Co's EV-to-EBITDA falls into.
Teh Seng Pharmaceutical Mfg Co's current Enterprise Value is NT$2,081.7 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Teh Seng Pharmaceutical Mfg Co's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was NT$153.3 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Teh Seng Pharmaceutical Mfg Co (ROCO:7860) has a EV-to-EBITDA of 13.58 as of Sep. 20, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Teh Seng Pharmaceutical Mfg Co. This is 39% above median its historical median of 9.75. Over the past decade, Teh Seng Pharmaceutical Mfg Co's EV-to-EBITDA has ranged from 7.43 to 13.57. According to the industry distribution chart, Teh Seng Pharmaceutical Mfg Co ranks #396 out of 746 companies in the Drug Manufacturers industry, placing it in the top 53.1%.
Is Teh Seng Pharmaceutical Mfg Co's EV-to-EBITDA too high?
Teh Seng Pharmaceutical Mfg Co's current EV-to-EBITDA of 13.58 is 39% above median its 10-year median of 9.75. Over the past 10 years, this metric has ranged from a low of 7.43 to a high of 13.57. The Drug Manufacturers industry median EV-to-EBITDA is 12.40. Teh Seng Pharmaceutical Mfg Co's value of 13.58 is 9.6% above this industry median. Based on the distribution chart, Teh Seng Pharmaceutical Mfg Co ranks #396 out of 746 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Teh Seng Pharmaceutical Mfg Co has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Teh Seng Pharmaceutical Mfg Co's EV-to-EBITDA compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Teh Seng Pharmaceutical Mfg Co ranks #396 out of 746 companies for EV-to-EBITDA. This places Teh Seng Pharmaceutical Mfg Co in the lower half of its industry. The industry median EV-to-EBITDA is 12.40. Teh Seng Pharmaceutical Mfg Co's value of 13.58 is 9.6% above this benchmark. Historically, Teh Seng Pharmaceutical Mfg Co's own EV-to-EBITDA has ranged from 7.43 to 13.57 over the past decade. While the company's 10-year median is 9.75 vs. the industry median of 12.40, Teh Seng Pharmaceutical Mfg Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Drug Manufacturers company?
The median EV-to-EBITDA among Drug Manufacturers companies is 12.40, based on 746 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Teh Seng Pharmaceutical Mfg Co's current EV-to-EBITDA of 13.58 is 9.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Teh Seng Pharmaceutical Mfg Co. For the Drug Manufacturers industry, the median EV-to-EBITDA is 12.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Teh Seng Pharmaceutical Mfg Co's current EV-to-EBITDA is 13.58, which is 39% above median its own 10-year median of 9.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Teh Seng Pharmaceutical Mfg Co stock overvalued right now?
Teh Seng Pharmaceutical Mfg Co (ROCO:7860) has a current EV-to-EBITDA of 13.58. The current EV-to-EBITDA is 13.58, which is 39% above median its 10-year median of 9.75 and 9.6% above the Drug Manufacturers industry median of 12.40. Teh Seng Pharmaceutical Mfg Co's overall GF Score™ is 30/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Teh Seng Pharmaceutical Mfg Co (ROCO:7860), the current EV-to-EBITDA is 13.58 as of Sep. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Teh Seng Pharmaceutical Mfg Co Ltd is engaged in the development and manufacturing of various pain relieving patches, cosmetic patches and biotechnology products. Its products include: Hydrogel Patches, Oil-Based Patches, Hot-Melt Patches, CMO & CRO for Transdermal Patch, Oral Film & Sublingual, Cosmetic Patches, Biotechnology Products and Daily Supplements.
30GF Score
Get the complete analysis for ROCO:7860
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:7860 has been successfully added to your 
